NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo

NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo

Bibliographic Details
Main Authors:	Spranger, Stefani, Frankenberger, Bernhard, Schendel, Dolores J
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309948/

Similar Items

Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
by: Cany, Jeannette, et al.
Published: (2013)

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
by: Yang, Chaoxing, et al.
Published: (2015)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chainnull Mice
by: Cai, Shanbao, et al.
Published: (2011)

Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70
by: Zobywalski, Anke, et al.
Published: (2007)

Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2Rγnull Mice
by: Ellerkamp, Verena, et al.
Published: (2011)

Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγnull mice
by: Ghinassi, Barbara, et al.
Published: (2011)

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
by: Schendel, Dolores J., et al.
Published: (2013)

Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγnull Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis
by: Milsom, Chloe C., et al.
Published: (2013)

Efficient derivation of embryonic stem cells from NOD-scid Il2rg−/− mice
by: Liu, Kang, et al.
Published: (2015)

Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγcnull Mice
by: Rapp, Anna E., et al.
Published: (2016)

Higher susceptibility of NOD/LtSz-scid Il2rg−/− NSG mice to xenotransplanted lung cancer cell lines
by: Kanaji, Nobuhiro, et al.
Published: (2014)

siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8+ T cells in NOD/SCID/IL2Rg(null) mice
by: van der Waart, Anniek B., et al.
Published: (2015)

Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2rγcnull Mice by Expression of Human IL-2
by: Abraham, Sojan, et al.
Published: (2012)

Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo
by: Shirasaki, Ryosuke, et al.
Published: (2012)

NOD-scidIl2rgtm1Wjl and NOD-Rag1nullIl2rgtm1Wjl: A Model for Stromal Cell–Tumor Cell Interaction for Human Colon Cancer
by: Maykel, Justin, et al.
Published: (2014)

Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
by: Ali, Niwa, et al.
Published: (2012)

Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγnull mice engrafted with human peripheral blood mononuclear cells
by: Nolte, Thomas, et al.
Published: (2013)

Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin
by: Jurczyk, Agata, et al.
Published: (2013)

Assessment of Benzene-Induced Hematotoxicity Using a Human-Like Hematopoietic Lineage in NOD/Shi-scid/IL-2Rγnull Mice
by: Takahashi, Masayuki, et al.
Published: (2012)

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
by: Gopalakrishnapillai, Anilkumar, et al.
Published: (2016)

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
by: Geiger, Christiane, et al.
Published: (2005)

Changes in the Proliferative Activity of Human Hematopoietic Stem Cells in NOD/SCID Mice and Enhancement of Their Transplantability after In Vivo Treatment with Cell Cycle Inhibitors
by: Cashman, J., et al.
Published: (2002)

The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice
by: Saito, Mineki, et al.
Published: (2014)

Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment
by: Van Pham, Phuc, et al.
Published: (2012)

Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities
by: Kim, Sung-Whan, et al.
Published: (2012)

Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling
by: Queudeville, M, et al.
Published: (2012)

Acceleration of Bone Repair in NOD/SCID Mice by Human Monoosteophils, Novel LL-37-Activated Monocytes
by: Zhang, Zhifang, et al.
Published: (2013)

D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
by: Righi, Marco, et al.
Published: (2013)

Dynamic Tracking Human Mesenchymal Stem Cells Tropism following Smoke Inhalation Injury in NOD/SCID Mice
by: Song, MeiJuan, et al.
Published: (2016)

Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone
by: Hori, Naoko, et al.
Published: (2016)

NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning
by: Verbiest, Tom, et al.
Published: (2016)

Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion
by: van Zuylen, Vanessa-Leigh, et al.
Published: (2015)

Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis
by: Unno, Kenji, et al.
Published: (2014)

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease
by: Lawson, Michelle A., et al.
Published: (2015)

Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice
by: LIU, XIANG, et al.
Published: (2014)

NOD Dendritic Cells Stimulated with Lactobacilli Preferentially Produce IL-10 versus IL-12 and Decrease Diabetes Incidence
by: Manirarora, Jean N., et al.
Published: (2011)

Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies
by: Schueler, Julia, et al.
Published: (2013)

Correction: Expansion of Cord Blood CD34+ Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse
Published: (2014)

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
by: Tel, Jurjen, et al.
Published: (2016)

Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo
by: Park, Chae Gyu
Published: (2014)